ArabFinance: Ibnsina Pharma (ISPH), Egypt’s fastest-growing and second-largest pharmaceutical distributor, has signed an agreement with Mundipharma in Egypt, a global pioneer in pharmaceuticals and diagnostics, to import and distribute Mundipharma imported products in Egypt.

The strong relationship between the two companies resulted in expanding business to see Ibnsina Pharma adding Mundipharma’s imported products beside Mudipharma’s local products which ibnsina Pharma already distribute in Egypt. Mundi pharma products covers six therapeutic areas; pain, oncology, respiratory, ophthalmology, specialty care and consumer health supporting over 4 billion patients across the globe.

“We are excited to have partnered with Mundipharma, a multinational company with a visionary approach and innovative spirit that improve the health and well-being of people around the world. This strategic partnership will allow Ibnsina Pharma to not only further strengthen its product offering but will give patients across Egypt unprecedented access to the latest pharmaceutical treatments available,” said Mohsen Mahgoub, Chairman of Ibnsina Pharma. “Expanding business with Mundipharma Egypt is a testament to the success of our business model, which provides our partners with distribution, importation, storage and value-added marketing services and has allowed us to become the distributor of choice for both foreign and domestic suppliers. The agreement capitalizes on Ibnsina’s wide distribution network. We expect to generate around 120 million EGP in sales from all Mundipharma’s products by end of 2020,” said Mahgoub.

Mundipharma Egypt aims for expanding its network of partners that offers the best support to patients to be able to access their innovative therapies and expand their coverage all over Egypt.

Ibnsina Pharma has over 350 international and domestic suppliers who trust Ibnsina Pharma to distribute their products to over 42,000 pharmacies, retail chains, wholesalers and healthcare institutions across Egypt’s governorates.

“Mundipharma aims to improve the lives of those who need our medicine the most, enabling everyone to live better. Mundipharma have 38 products across six therapeutic areas with a distribution network covering six continents through 8 manufacturing sites. We are feeling optimistic to sign this distribution agreement with Ibnsina Pharma, trusting the high-efficiency, and the level of services offered to support our patients throughout Egypt.

I look forward to growing our partnership, offering patients in Egypt access to the latest innovations” said Dr. Ashraf Allam, Vice President Mundipharma Middle East, Africa, Turkey at Mundipharma

Copyright © 2019 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.